HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data
- Resource Type
- Abstract
- Source
- In
Value in Health June 2023 26(6) Supplement:S262-S263 - Subject
- Language
- ISSN
- 1098-3015